OBRR Lab

The Food and Drug Administration is forecasting the procurement of a real-time PCR instrument through its Center for Biologics Evaluation and Research, with the opportunity posted on May 25, 2026. The procurement falls under NAICS code 423450, which relates to medical and dental equipment and supplies merchant wholesaling, indicating the intent to acquire advanced laboratory instrumentation for diagnostic or research purposes. The place of performance and specific delivery location have not been defined in the forecast, and the office address details remain unspecified, suggesting that final logistics may be determined following award. The program point of contact is the CBER Acquisition Liaison, reachable at cberacquisitions@fda.hhs.gov, while the contracting officer’s identity is still pending. This forecast serves as a preliminary notice to potential vendors, providing no guaranteed funding or award timing, and is intended to allow industry to prepare for an upcoming solicitation. Interested parties are directed to the provided URL for future updates and formal solicitation information.